5-(4-chlorobenzoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrolo-1-carboxylic acid
5-(4-chlorobenzoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrolo-1-carboxylic acid(66635-89-0)
- Name: 5-(4-chlorobenzoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrolo-1-carboxylic acid
- Synonyms:5-(4-chlorobenzoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrolo-1-carboxylic acid
- Molecular Formula:
- Molecular Weight:289.718
- CAS Registry Number:66635-89-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.66635-89-0 Ketorolac Impurity 15
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.66635-89-0 Ketorolac Impurity 13
Assay:98% Appearance:solid Package:mg,g Storage:According to the product properties, it is packaged and stored at room temperature, frozen, refrigerated, protected from light, moisture, and inert gas protection etc. Transportation:By Air,By Courier Application:Laboratory research, pharmaceutical research, new medicinal registration, preclinical/clinical pharmacokinetic tests during the development of new drugs (ADME/DMPK, mass balance, consistency studi...
Min. Order:0
Supplier:Nanjing HuaNuo Bio-Pharmacuetical Co.,Ltd [
China (Mainland)]
Other Product
- 882185-19-5/tert-butyl 4-(2-fluoro-4-{(5R)-5-[(isoxazol-3-yloxy)methyl]-2-oxo-1,3-oxazolidin-3-yl}phenoxy)piperidine-1-carboxylate
- 960073-94-3/C20H26N2O3
- 188788-14-9/E 3-(3-amino-4-chloro-6-fluoro-2-methoxyphenyl)-1-methyl-6-trifluoromethyl-2,4(1H,3H)-pyrimidinedione
- 1284223-66-0/3-butyl-2-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-1,2-dihydroisoquinoline
- 1310039-12-3/(S)-1,1-dioxo-2-[3-(2',4',5'-trifluoro-biphenyl-4-yloxymethyl)-benzyl]-1λ6-[1,2]thiazinane-3-carboxylic acid
- 69212-67-5/(3-methyl-butyl)-thiazol-2-yl-amine
- 887776-45-6/2,6,10-tris(trifluoromethanesulfonyl)-3,7,11-tris(hexyloxy)triphenylene
- 473797-77-2/C18H20N2O6
- 1184761-95-2/(R)-2-{(4R,5R,6S)-6-[(S)-2-(4-methoxybenzyloxy)-1-methylethyl]-2,2,5-trimethyl-[1,3]dioxan-4-yl}-2,6-dimethyl-hept-5-enoic acid
- 75745-53-8/1-(5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone
- 172092-45-4/1-benzyl-4-methylhexahydro-1H-1,4-diazepin-6-ol
- 144155-04-4/7-Chloro-3-(2-trifluoromethyl-phenyl)-3,4-dihydro-2H,10H-acridine-1,9-dione
- 1433663-03-6/C25H24F2N4O2
- 1160964-93-1/3-hydroxypropyl 2-fluoro-4-[(3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino]-benzoate
- 1122573-42-5/methyl 2-diazo-3-(ethyl(methyl)amino)-3-oxopropanoate
- 1421267-09-5/C21H17BrClN3O2
- 120695-56-9/[(E)-3-Cyano-2-(3,4-dimethoxy-phenyl)-propenyl]-trimethyl-ammonium; iodide
- 1416553-95-1/C17H16ClFN4O
- 86722-05-6/tetrabutylammonium bis(pentachlorophenyl)silver(I)
- 66635-89-0/5-(4-chlorobenzoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrolo-1-carboxylic acid
- 1299488-97-3/1-(2-(1-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzyl)piperidin-4-yl)-1H-indazol-5-yl)-3-(pyridin-4-yl)urea
- 1407499-47-1/(E)-tert-butyl 3-(3-(1-isopropyl-2-(4-(2-morpholinoethoxy)benzoyl)hydrazinyl)-3-oxoprop-1-enyl)-1H-indole-1-carboxylate
- 1383158-02-8/C14H20N4O4
- 89196-64-5/dimethyl 3-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)phthalate
- 1402154-02-2/(2R,8S,9S,10R,13S,14S,17S)-2-(4-chlorophenoxy)-3-(methoxycarbonyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid
- 84568-09-2/trimethyl(2,4-pentadienyl)stannane
- 852519-44-9/C33H42O5
- 1253186-71-8/2,6-difluoro-N-[1-({2-methyl-4-[(2-pyridinylmethyl)oxy]phenyl}methyl)-1H-pyrazol-3-yl]benzamide
- 1400664-36-9/C28H31N3O3
- 321582-07-4/(S)-3-(2,5-dimethoxy-4-methylphenyl)-6-methyl-5-heptenyl acetate